Log in

OTCMKTS:CLPBY - COLOPLAST A/S/ADR Stock Price, Forecast & News

-0.30 (-2.20 %)
(As of 02/26/2020 04:25 AM ET)
Today's Range
Now: $13.32
50-Day Range
MA: $12.98
52-Week Range
Now: $13.32
Volume50,600 shs
Average Volume43,362 shs
Market Capitalization$28.77 billion
P/E Ratio47.57
Dividend Yield1.62%
Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Previous SymbolNASDAQ:CLPBY



Sales & Book Value

Annual Sales$2.76 billion
Cash Flow$0.29 per share
Book Value$0.48 per share


Net Income$585.21 million


Outstanding Shares2,160,000,000
Market Cap$28.77 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive CLPBY News and Ratings via Email

Sign-up to receive the latest news and ratings for CLPBY and its competitors with MarketBeat's FREE daily newsletter.

COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Frequently Asked Questions

What is COLOPLAST A/S/ADR's stock symbol?

COLOPLAST A/S/ADR trades on the OTCMKTS under the ticker symbol "CLPBY."

How often does COLOPLAST A/S/ADR pay dividends? What is the dividend yield for COLOPLAST A/S/ADR?

COLOPLAST A/S/ADR declared a Semi-Annual dividend on Friday, April 5th. Investors of record on Tuesday, May 7th will be paid a dividend of $0.04 per share on Wednesday, May 22nd. The ex-dividend date is Monday, May 6th. View COLOPLAST A/S/ADR's Dividend History.

How were COLOPLAST A/S/ADR's earnings last quarter?

COLOPLAST A/S/ADR (OTCMKTS:CLPBY) released its earnings results on Thursday, May, 2nd. The company reported $0.07 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.07. The company had revenue of $688.45 million for the quarter. COLOPLAST A/S/ADR had a net margin of 21.62% and a return on equity of 69.30%. View COLOPLAST A/S/ADR's Earnings History.

What guidance has COLOPLAST A/S/ADR issued on next quarter's earnings?

COLOPLAST A/S/ADR updated its FY 2020 Pre-Market earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.19473-19.37412 billion.

What is the consensus analysts' recommendation for COLOPLAST A/S/ADR?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COLOPLAST A/S/ADR in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for COLOPLAST A/S/ADR.

Has COLOPLAST A/S/ADR been receiving favorable news coverage?

Press coverage about CLPBY stock has trended positive on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. COLOPLAST A/S/ADR earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for COLOPLAST A/S/ADR.

Who are some of COLOPLAST A/S/ADR's key competitors?

What other stocks do shareholders of COLOPLAST A/S/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other COLOPLAST A/S/ADR investors own include Advanced Micro Devices (AMD), Broadcom (AVGO), Exelixis (EXEL), Aimmune Therapeutics (AIMT), Baidu (BIDU), GW Pharmaceuticals PLC- (GWPH), Intuitive Surgical (ISRG), Kala Pharmaceuticals (KALA), Intellia Therapeutics (NTLA) and NVIDIA (NVDA).

Who are COLOPLAST A/S/ADR's key executives?

COLOPLAST A/S/ADR's management team includes the folowing people:
  • Mr. Kristian Villumsen, Pres & CEO (Age 49)
  • Mr. Anders Lonning-Skovgaard, Exec. VP & CFO (Age 47)
  • Mr. Allan Rasmussen, Exec. VP of Global Operations (Age 52)
  • Ellen Bjurgert, VP of Investor Relations
  • Lina Danstrup, Sr. Media Relations Mang. of Corp. Communications

How do I buy shares of COLOPLAST A/S/ADR?

Shares of CLPBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is COLOPLAST A/S/ADR's stock price today?

One share of CLPBY stock can currently be purchased for approximately $13.32.

How big of a company is COLOPLAST A/S/ADR?

COLOPLAST A/S/ADR has a market capitalization of $28.77 billion and generates $2.76 billion in revenue each year. The company earns $585.21 million in net income (profit) each year or $0.30 on an earnings per share basis. COLOPLAST A/S/ADR employs 12,234 workers across the globe.View Additional Information About COLOPLAST A/S/ADR.

What is COLOPLAST A/S/ADR's official website?

The official website for COLOPLAST A/S/ADR is http://www.coloplast.com/.

How can I contact COLOPLAST A/S/ADR?

COLOPLAST A/S/ADR's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The company can be reached via phone at 45-4911-1111 or via email at [email protected]

MarketBeat Community Rating for COLOPLAST A/S/ADR (OTCMKTS CLPBY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  148 (Vote Underperform)
Total Votes:  281
MarketBeat's community ratings are surveys of what our community members think about COLOPLAST A/S/ADR and other stocks. Vote "Outperform" if you believe CLPBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLPBY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel